Berlin – September 16, 2026 -- Aignostics has opened early access to PathoSearch, a visual search engine that retrieves diagnosed reference pathology cases from a single screenshot of an H&E slide, targeting the rare and complex cases that make up as much as 20% of a pathologist's caseload.

Cordova, Tenn. – September 16, 2026 -- Aesthetic Management Partners (AMP) has added ATTIVA®, an intelligent subdermal radiofrequency platform developed by Italy's Tema Medicina S.R.L., to its aesthetic technology portfolio, the company announced.

Berlin – September 16, 2026 -- XPPen's newly unveiled Magic Pro 13 secured four "Best of IFA 2026" honors at the Berlin trade show, with recognition from Gadgety Awards, TechRadar, Yanko Design, and Android Headlines.

Los Angeles – September 11, 2026 -- Triple B Media has struck a partnership with Silver Sports & Entertainment to operate SLVR, a new free ad-supported streaming television (FAST) channel programmed by the Los Angeles Kings and its AHL affiliate, the Ontario Reign.

Atlanta – September 16, 2026 -- March Networks and VIVOTEK will make their first joint appearance at Global Security Exchange (GSX) 2026, five months after their April merger, showcasing new product integrations and a customer deployment with a North American apparel chain operating more than 500 stores.

Duluth, Ga. – September 16, 2026 -- CINC Systems has unveiled Community Intelligence, a platform-wide AI standard the company says has already helped clients save more than 36,000 hours and $1.13 million in labor costs year to date across invoice, budget and board packet workflows.

Unnao, India -- Crown Holdings, Inc. (NYSE: CCK) broke ground on September 9, 2026 on its first beverage can manufacturing facility in India, a plant designed to produce approximately 2.2 billion aluminum beverage cans annually once operational.

Arlington, Mass. – – September 16, 2026 -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) has dosed the first two patients in the EXACT Study, a Phase 2b trial evaluating its investigational drug exaluren in patients with nonsense mutation Alport syndrome (NMAS), a rare kidney disease with no FDA-approved therapy targeting its genetic cause.

Oklahoma City – September 16, 2026 -- Acarix AB announced that a peer-reviewed study published in PLOS Digital Health found its seismocardiography (SCG) technology can detect heart failure with diagnostic accuracy comparable to NT-proBNP, the current standard blood test, while producing significantly fewer false positives.

Boisbriand, QC – September 16, 2026 -- Vision Marine Technologies Inc. (NASDAQ: VMAR) has been invited to the Suntex Marinas National Conference in Texas, running September 22-25, 2026, following its role as Title Sponsor of the Lake Berryessa Electric Boat Festival in June 2026 at Suntex-owned Pleasure Cove Marina in Napa, California.